Similar articles

• [Drug-induced esophagitis, esophageal ulcer, gastro-duodenal ulcer, and small intestinal ulcer].

  Matsuhashi N, Sakurai Y. Matsuhashi N, et al. Nihon Rinsho. 2007 Oct 28;65 Suppl 8:504-8. Nihon Rinsho. 2007. PMID: 18074591 Review. Japanese. No abstract available.
• Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women.

  Lanza FL, Hunt RH, Thomson AB, Provenza JM, Blank MA. Lanza FL, et al. Gastroenterology. 2000 Sep;119(3):631-8. doi: 10.1053/gast.2000.16517. Gastroenterology. 2000. PMID: 10982755 Clinical Trial.
• Esophageal irritation due to alendronate sodium tablets: possible mechanisms.

  Peter CP, Handt LK, Smith SM. Peter CP, et al. Dig Dis Sci. 1998 Sep;43(9):1998-2002. doi: 10.1023/a:1018894827961. Dig Dis Sci. 1998. PMID: 9753265
• Mucosal irritant potential of a potassium-sparing diuretic and of wax-matrix potassium chloride.

  Ryan JR, McMahon FG, Akdamar K, Ertan A, Agrawal N. Ryan JR, et al. Clin Pharmacol Ther. 1984 Jan;35(1):90-3. doi: 10.1038/clpt.1984.13. Clin Pharmacol Ther. 1984. PMID: 6690174
• [Non-steroidal anti-inflammatory agents and digestive lesions].

  Bellanger J, Pointereau-Bellanger A. Bellanger J, et al. Ann Gastroenterol Hepatol (Paris). 1989 Nov;25(6):237-48. Ann Gastroenterol Hepatol (Paris). 1989. PMID: 2694919 Review. French. No abstract available.